Authors' Reply: Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm: Is Propensity Score Matching Necessary?
사설/논평
0/5 보강
APA
Zhao K, Sotirchos V, et al. (2026). Authors' Reply: Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm: Is Propensity Score Matching Necessary?. Journal of vascular and interventional radiology : JVIR, 37(2), 107917. https://doi.org/10.1016/j.jvir.2025.107917
MLA
Zhao K, et al.. "Authors' Reply: Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm: Is Propensity Score Matching Necessary?." Journal of vascular and interventional radiology : JVIR, vol. 37, no. 2, 2026, pp. 107917.
PMID
41344076 ↗
같은 제1저자의 인용 많은 논문 (5)
- PCa-Mamba: Spatiotemporal state space models for prostate cancer detection in multi-parametric MRI.
- Evidence Supporting the Shift Towards Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States.
- Prospects for leveraging knowledge on ISG and NF-kB effector functions into anti-HBV therapies.
- Eugenol as a game-changer: overcoming osimertinib resistance in non-small cell lung cancer by inhibiting glycolysis via the tripartite motif containing 59/extracellular signal-regulated kinase pathway.
- Erratum: [Corrigendum] FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma and .